Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients With Multiple Myeloma

Leukemia - United Kingdom
doi 10.1038/s41375-020-0828-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Dynamics of Multiple Myeloma Tumor Therapy With a Recombinant Measles Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2009English

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

International Journal of Hematology
Hematology
2020English

Specific Elimination of CD133+ Tumor Cells With Targeted Oncolytic Measles Virus

Cancer Research
Cancer ResearchOncology
2013English

Regulatory T Cell Depletion Enhances Tumor Specific CD8 T-Cell Responses, Elicited by Tumor Antigen NY-ESO-1b in Hepatocellular Carcinoma Patients, in Vitro

International Journal of Oncology
Cancer ResearchOncology
2010English

Systemic Therapy With Oncolytic Myxoma Virus Cures Established Residual Multiple Myeloma in Mice

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

Frontiers in Immunology
AllergyImmunology
2018English

Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Bacterial-Mediated Knockdown of Tumor Resistance to an Oncolytic Virus Enhances Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Oncolytic Virotherapy for Multiple Myeloma Using a Tumour-Specific Double-Deleted Vaccinia Virus

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy